Research programme: dendritic cell vaccines - ImmunomedicsAlternative Names: Dendritic cell vaccine - Immunomedics; Milatuzumab-Fab-A3B3
Latest Information Update: 08 Apr 2011
At a glance
- Originator Immunomedics
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer